Skip to main content
. Author manuscript; available in PMC: 2010 May 4.
Published in final edited form as: Breast Cancer Res Treat. 2009 Jul 2;120(1):165–168. doi: 10.1007/s10549-009-0453-7

Table 1.

Observed sequence variations in the MERIT40 gene

Location Nucleotide change Effect on protein rs number Frequency of heterozygotes, % (n/N) P (OR; 95% CI)

Familial cases Controls
Exon 3 c.342C > T Asn114Asn 4.0 (5/125) 3.7 (7/192) 1.0 (1.1; 0.3–3.6)
Intron 3 c.344 + 41A > T rs10420922 49.6 (62/125) 44.3 (85/192) 0.4 (1.2; 0.8–1.9)
Exon 4 c.393C > T Phe131Phe 0.8 (1/125) 1.6 (3/192) 1.0 (0.5; 0.1–4.9)
Intron 8a c.787 − 6C > T rs10406920 39.2 (49/125) 37.5 (72/192) 0.8 (1.1; 0.7–1.7)
Exon 9 c.821A > G Lys274Arg 1.6 (2/125) 1 (2/192) 0.6 (1.5; 0.2–11.1)
Exon 9a c.837G > A Lys279Lys rs8170 39.2 (49/125) 37.5 (72/192) 0.8 (1.1; 0.7–1.7)
Exon 9b c.*87G > A 0.8 (1/125) − (0/192) 0.4 (1.0; 0.98–1.01)

The following sequence information was used: NC_000019 (genomic DNA), NM_001033549.1 (mRNA), and NP_001028721 (protein) OR odds ratio, CI confidence interval

a

rs10406920 and rs8170 were in linkage

b

3′UTR change